Exclusive Podcast Series: Preclinical to clinical translation - the "tool" box

In our exclusive three-part podcast series, Prof. Martin Wehling, Managing Director at the University of Heidelberg’s Institute for Experimental & Clinical Pharmacology, speaks about current developments and challenges in translational medicine today.

Follow the links to download the podcast or to listen online:

Preclinical to clinical translation - the “tool box” (Part 1) In part one of our three-part podcast series, Prof. Martin Wehling, Managing Director at the University of Heidelberg’s Institute for Experimental & Clinical Pharmacology, speaks about current developments and challenges in translational medicine today.


Preclinical to clinical translation - the “tool box” (Part 2) In part two of our three-part podcast series, Prof. Wehling speaks about the standardized translational “tool box”, the current efficacy of physiologically based pharmacokinetic modelling (PBPK), and the relevance of biomarkers to translational processes.


Preclinical to clinical translation - the “tool box” (Part 3) In the third and final part of our podcast series on the preclinical to clinical translation tool box, Prof. Wehling gives insight into the role of pharmaceutical industry, joint public-private ventures and the future of Preclinical to clinical translation.